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Vaccinia virus (VACV), the model poxvirus, produces two
types of infectious particles: mature virions (MVs) and
extracellular virions (EVs). EV particles possess two mem-
branes and therefore require an unusual cellular entry
mechanism. By a combination of ﬂuorescence and electron
microscopy as well as ﬂow cytometry, we investigated
the cellular processes that EVs required to infect HeLa
cells. We found that EV particles were endocytosed, and
that internalization and infection depended on actin re-
arrangements, activity of Na
þ/H
þ exchangers, and signal-
ling events typical for the macropinocytic mechanism of
endocytosis. To promote their internalization, EVs were
capable of actively triggering macropinocytosis. EV infec-
tion also required vacuolar acidiﬁcation, and acid expo-
sure in endocytic vacuoles was needed to disrupt the outer
EV membrane. Once exposed, the underlying MV-like
particle presumably fused its single membrane with the
limiting vacuolar membrane. Release of the viral core into
the host cell cytosol allowed for productive infection.
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Introduction
To successfully replicate, viruses have to deliver their genome
and accessory proteins into the cytosol or nucleus of a host
cell. This implies that virus particles or their packaged
genome must cross the plasma membrane (PM) or the limit-
ing membrane of endocytic vacuoles. In the case of animal
viruses that have a lipid bilayer envelope, the critical step of
membrane penetration involves fusion of the viral membrane
with a cellular membrane. The packaged genome is thus
released into the cytosol (Marsh and Helenius, 2006).
Vaccinia virus (VACV) is the prototypic poxvirus and
is closely related to variola virus, the causative agent
of smallpox (Damon 2007). Poxviruses are enveloped DNA
viruses that use a fusion mechanism to enter cells (Senkevich
et al, 2005). They are unusual because they exist in two
different, infectious forms (Moss 2007). In addition to single
membrane containing particles (mature virions, MVs)
(Hollinshead et al, 1999; Cyrklaff et al, 2005), particles
are produced that contain two concentric membranes (extra-
cellular virions, EVs) (Smith et al, 2002). MVs are released
after lysis of infected cells and mediate host-to-host transmis-
sion (Smith et al, 2003; Moss 2007). EVs leave the cell by
exocytosis and are required for virus spread within a tissue or
from tissue to tissue (Payne, 1980). An EV particle consists of
an MV-like particle surrounded by an additional membrane
containing cellular proteins and at least six viral proteins
unique to the EV (Payne, 1978, 1979; Smith et al, 2002). With
two membranes, a conventional mechanism of entry is not
possible. Loss of the outer membrane by fusion would release
a particle into the cytosol that is still covered by the inner
membrane. Such a particle is unlikely to cause productive
infection.
Recent studies have shown that the majority of MVs
enter cells by endocytosis and penetration occurs by
membrane fusion in intracellular vacuoles (Townsley et al,
2006; Townsley and Moss, 2007). The entry process involves
macropinocytic internalization induced by phosphati-
dylserine (PS) exposed on the MV membrane (Zwartouw,
1964; Ichihashi and Oie, 1983; Huang et al, 2008; Mercer and
Helenius, 2008; Mercer et al, 2010).
Available information on EV entry suggests that the outer
of the two membranes is simply lost or ruptured revealing the
underlying MV-like membrane, which then undergoes
fusion with the PM or the limiting membrane of a vacuole
(Moss, 2006). The core could thus be delivered into the
cytosol without a membrane. The model proposing rupture
of the outer membrane of the EV is based on the following
observations: (1) The entry/fusion complex (EFC) present in
the inner of the two membranes is essential for EV infection
(Senkevich et al, 2004a,b). (2) The outer membrane of
the EV is fragile and sensitive to in vitro treatment with
reduced pH and anionic polysaccharides (Ichihashi, 1996;
Vanderplasschen et al, 1998a; Law et al, 2006). EV disruption
with anionic polysaccharides has been shown to depend on
two EV-speciﬁc proteins, A34 and B5 (Law et al, 2006;
Roberts et al, 2009). (3) Electron micrographs of cell surface
bound EVs show the presence of ruptured EV membranes
covering MV-like particles (Law et al, 2006).
However, it has been observed that antibodies directed
against MV-membrane proteins that neutralize MV infection,
fail to neutralize infection by EVs (Ichihashi, 1996;
Vanderplasschen et al, 1998a). This suggests that upon
rupture of the outer EV membrane, the underlying MV-like
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3647particle is inaccessible to antibodies. One explanation could
be that EV rupture takes place at the PM and the disrupted
outer membrane covers the PM-bound MV-like particle.
Another possibility is that rupture occurs only after endocytic
internalization of the intact EV particle. Several studies have
addressed the EV entry process using epithelial cell
lines and human monocyte-derived dendritic cells (DCs)
with conﬂicting results (Ichihashi, 1996; Vanderplasschen
et al, 1998a; Locker et al, 2000; Law et al, 2006; Roberts
et al, 2009; Sandgren et al, 2010).
In this study, we used ﬂow cytometry-based assays
and microscopy in combination with different perturbants
of cellular proteins and functions to analyse EV infection of
HeLa cells. We found that VACV EVs induced their own
endocytic uptake by macropinocytosis. Acidiﬁcation of en-
docytic compartments was needed to trigger disruption of EV
membranes, presumably followed by fusion of the underlying
virus particles with limiting membranes of endocytic orga-
nelles. This would release virus cores into the cytosol and
allow productive infection.
Results
Quality of EV particles
In our study, we used EVs released into the medium as free
particles by infected cells. They correspond to the population
of VACV particles responsible for long-range spread in the
infected organism (Payne, 1980). The outer membrane of EVs
is fragile and easily disrupted during puriﬁcation (Ichihashi,
1996; Vanderplasschen and Smith, 1997) (our unpublished
results). We therefore used freshly produced EVs of VACV
strains Western Reserve (WR) and International Health
Department J (IHD-J) in clariﬁed supernatants of infected
RK13 cells without further puriﬁcation.
To quantify the fraction of intact EVs, we used the mono-
clonal antibody (MAb) 7D11, which binds to the L1 protein in
the MV membrane, and selectively neutralizes MVs and
broken EVs (Figure 1A) (Wolffe et al, 1995). Using plaque
assays, we determined that MVs of VACV strains WR
and IHD-J were neutralized by 5mg/ml 7D11. Depending on
the preparation, 10–40% of WR and IHD-J infectivity in the
supernatant was insensitive to 7D11 and therefore repre-
sented infectivity caused by intact EVs. In contrast, WR
DA34R, a deletion mutant of the EV membrane protein A34
known to contain stabilized EV membranes (Law et al, 2006;
Husain et al, 2007), was B90% insensitive to 7D11.
To conﬁrm the presence of intact EVs in the supernatant,
we analysed VACV particles released from RK13 cells by
confocal microscopy. To discriminate between MVs and
EVs, we used a recombinant IHD-J strain expressing two
different ﬂuorescent fusion proteins: mCherry was fused to
the core protein A5 and GFP to the EV-speciﬁc outer mem-
brane protein F13. Both MVs and EVs therefore contained a
red ﬂuorescent core and could be visualized as discrete spots.
The majority of particles in the supernatant of infected RK13
cells (83%) was also positive for the outer EV membrane
(green ﬂuorescent). Some green ﬂuorescent particles without
a red ﬂuorescent core were observed, likely representing EV
Figure 1 Quality of EV particles. (A) EV quality—infectious particles. Clariﬁed supernatants of RK13 cells infected with VACV IHD-J, WR,
or WR DA34R were titrated on BSC-40 cells after incubation with or without Mab 7D11. As a control, puriﬁed MVs of the same strains were
subjected to the same treatment and titration. Plaque numbers were normalized to untreated virus samples. Results represent the average of three
independent experiments (mean±s.e.m.). (B) EV quality—ﬂuorescent particles. Clariﬁed supernatants of RK13 cells infected with IHD-J
mCherry–A5 F13–GFP were incubated with 7D11, bound to cover slips, and ﬁxed. 7D11 was visualized with AF 647 goat anti-mouse and images
recorded by confocal microscopy. Virus particles were detected by their ﬂuorescent core and assigned to the following categories: MV 7D11
(mCherry), MVþ7D11 (mCherry and 7D11 staining), EV 7D11 (mCherry, GFP), or EVþ7D11 (mCherry, GFP, and 7D11 staining). Average values
of three independent experiments are shown±s.e.m. (C) Fluorescent EVs. Representative images from (B). Examples of a neutralized MV
(MVþ7D11, open arrowhead), an intact EV (EV 7 D 1 1 ,a r r o w ) ,a n dad i s r u p t e dE V( E Vþ7D11, closed arrowhead) are highlighted.
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cores, data not shown).
To determine the fraction of intact EVs, cell supernatants
containing recombinant IHD-J viruses were preincubated
with 7D11, applied to a cover slip, and stained with a
ﬂuorescently labelled secondary antibody. MVs and broken
EVs with exposed L1 were expected to be stained whereas
intact EVs were not. Figure 1C shows a ﬁeld with MVs
(mCherry and 7D11 staining; open arrowhead), disrupted
EVs (mCherry, GFP, and 7D11 staining; closed arrowhead),
and intact EVs (mCherry and GFP, arrow). Analysis of 4600
virus particles in three independent experiments showed that
17% of the viruses were MVs, 69% were disrupted EVs, and
14% were intact EVs (Figure 1B). This amount of intact EVs
corresponded to the fraction of 7D11-insensitive EVs deter-
mined by plaque assay for the same supernatants (data not
shown).
After analysing EV particles for both infectivity and integ-
rity, we concluded that MAb 7D11 could be used to discrimi-
nate between intact and broken EVs. It was evident that the
majority of IHD-J and WR EVs released into the supernatant
did not possess an intact second membrane. In most
instances—judging by the presence of F13–GFP—the dis-
rupted EV membrane remained associated with the virus
particle. Disruption of the outer membrane did not interfere
with the infectivity of EVs.
EV particles are endocytosed
For productive infection, both EV membranes must be
removed during the entry process. While it has been
suggested that removal of the outer membrane of EVs hap-
pens already on the PM (Law et al, 2006), it is conceivable
that the EV particles are endocytosed ﬁrst with loss of the
outer EV membrane taking place in endocytic compartments.
To test whether EVs can be internalized with their outer
membrane still in place, we used recombinant IHD-J EVs
containing F13–GFP to infect HeLa cells for 30min at 371C.
Samples were stained for the EV membrane protein B5
under non-permeabilizing conditions to distinguish between
external and intracellular EVs (Figure 2B). A fraction of EV
particles (green spots; white arrows, inset) was inaccessible
to antibody staining, indicating they were internalized.
To control for changes in the B5 epitope or inappropriate
staining, the same procedure was performed either with cells
in which the virus had not been allowed to internalize
(bound EVs, Figure 2A) or with cells permeabilized with
saponin after ﬁxation (Figure 2C). In both conditions, all EV
particles were stained for B5.
To assure that intact EV particles, and not only dissociated
EV membranes without cores were internalized, HeLa cells
were infected with IHD-J mCherry–A5 F13–GFP EVs and
subjected to B5 staining under non-permeabilizing conditions
(Figure 2D). That a subpopulation of the dual-coloured EVs
was not stained (white arrows, inset) indicated that EV
particles were internalized with the outer membrane. Virus
cores or MVs without an EV membrane (closed arrowhead)
and internalized EV membranes without a core (open arrow-
head) were also observed. These may represent intermediates
of the EV entry process or may have been internalized from
the inocculum.
To conﬁrm these ﬁndings, HeLa cells incubated with
IHD-J F13–GFP EVs for 30min were analysed by electron
microscopy for the presence of internalized particles with EV
membranes. Ultrathin sections of cells were subjected to
negative staining to visualize the EV membrane.
Immunogold labelling directed against GFP was used to
detect the F13–GFP fusion protein in the EV membrane
(Figure 2E and F; Supplementary Figure S1). Gold-labelled
EV particles were found both at the PM, often next to
membrane protrusions (Figure 2E; Supplementary Figure
S1A and B), and in intracellular vesicles (Figure 2E and F;
Supplementary Figure S1A–F). In some particles, two mem-
branes could be clearly distinguished (arrows in Figure 2F;
Supplementary Figure S1D), conﬁrming that full EV particles
were endocytosed. In a few particles (Supplementary Figure
S1F), the EV membrane was partly disrupted. EV membranes
devoid of cores were also observed bound to the PM. They
may have originated from free membranes in the inoculum,
or from particles disrupted at the PM.
Internalization of EVs was conﬁrmed using ﬂow cytome-
try. IHD-J F13–GFP EVs were bound to HeLa cells on ice and
incubated either on ice or at 371C for a further 30min. Bound
virus particles were removed by trypsin digestion and the
cells were subjected to ﬂow cytometry to determine the cell-
associated ﬂuorescence from internalized particles (Figure 3A
and B). The low temperature control showed that bound EVs
could be almost completely removed by trypsin, whereas
cells incubated at 371C were green ﬂuorescent, conﬁrming
the presence of internalized IHD-J F13–GFP EVs. When cells
were detached with EDTA, ﬂuorescence of both bound and
internalized EVs could be measured (Figure 3A and C).
Fluorescence intensities with and without incubation at
371C were comparable, conﬁrming that GFP ﬂuorescence
and virus binding was not affected by incubation at 371C.
These experiments showed that cell-bound EVs were
rapidly internalized by endocytosis. Although disrupted EVs
were not distinguished from intact EVs in these experiments,
we could show by ﬂuorescence microscopy, electron micro-
scopy, and ﬂow cytometry that the outer membrane of EVs
was not lost before internalization.
EVs are internalized by macropinocytosis
To analyse the endocytic mechanism responsible for EV
internalization, and to test whether endocytosis was required
for infection by intact EVs, we infected HeLa cells in the
presence of a spectrum of small compound inhibitors known
to affect endocytic processes. GFP-expressing viruses and
ﬂow cytometry were used to quantify infection by VACV
EVs of the strains IHD-J and WR (Figure 4A and C).
To assure that infection by intact EVs was speciﬁcally
analysed, we pretreated EV-containing supernatants with
Mab 7D11 for all infection experiments. Since cells infected
with VACV WR released less EVs into the medium than cells
infected with strain IHD-J, WR EV supernatants were con-
centrated by sedimentation before MV neutralization. This
did not signiﬁcantly reduce the fraction of intact EVs (data
not shown). In all cases, MVs were used as controls. IHD-J
and WR MVs have been found to induce macropinocytosis in
host cells, and to use this pathway as a route of productive
infection (Mercer and Helenius, 2008).
Inhibition of clathrin-mediated endocytosis by chlorpro-
mazine (Chlo) affected neither IHD-J EV nor MV infection
(Figure 4A). Infection with EVs and MVs was only moder-
ately affected by the general protein kinase inhibitor
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tyrosine-kinase inhibitor genistein (Geni) or the posphoinosi-
tide 3-kinase inhibitor wortmannin (Wort). In contrast, infec-
tion with both EVs and MVs was dramatically blocked by
Iressa, an inhibitor of the epidermal growth factor receptor
(EGFR); by the protein kinase C (PKC) inhibitor calphostin C
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activated kinase 1 (PAK1); and by the smooth muscle myosin
light chain kinase (smMLCK) inhibitor ML-7. Rottlerin (Rott),
originally described to speciﬁcally inhibit PKCd (Gschwendt
et al, 1994), but later found to have multiple effects (Davies
et al, 2000; Soltoff, 2001; Kayali et al, 2002; Tillman et al,
2003), nearly abolished infection. Perturbation of actin
dynamics with cytochalasin D (Cyto) and jasplakinolide
(Jasp) strongly reduced EV infection; the block of infection
was, however, even more pronounced for MVs. An inhibitor
of Na
þ/H
þ antiporters, ethylisopropyl amiloride (EIPA), also
efﬁciently prevented infection with both EVs and MVs. The
requirement of PAK1, smMLCK, PKC activity, actin dynamics,
and sodium–proton exchangers strongly suggested an endo-
cytic process categorized as macropinocytosis (Mercer and
Helenius, 2009).
To determine if the inhibitors of infection blocked macro-
pinocytic uptake of EVs, we quantiﬁed internalization of
IHD-J EVs and MVs using ﬂow cytometry (Figure 4B). For
EV internalization experiments, IHD-J EVs containing F13–
GFP were used without neutralization as 7D11 treatment did
not affect endocytic uptake of neutralized, disrupted EVs
(data not shown). For MV internalization experiments, MV
particles incorporating EGFP–A5 in the core were employed
(Supplementary Figure S2). Bound MVs, in contrast to
EVs, were only partially removed by trypsin digestion (sam-
ple MV 01C (int.)). Signal intensity of cells incubated at
371C was signiﬁcantly higher than that of cells kept at 01C
allowing for quantiﬁcation after background subtraction.
Rott, IPA-3, Cyto, Jasp, and EIPA efﬁciently blocked inter-
nalization of both EVs and MVs, conﬁrming that the observed
effects on infection occurred due to impaired endocytic
uptake.
The inhibitors that blocked IHD-J EV infection were then
tested against WR EVs (Figure 4C). Inhibition of EGFR, PAK1,
smMLCK, PKC, actin dynamics, and Na
þ/H
þ antiport
caused a strong reduction of WR EV infection. These results
indicated that EVs of both IHD-J and WR strains exploited
macropinocytosis for infection.
Throughout these infection experiments, neutralized MVs
and neutralized disrupted EVs were present in the inocula.
Thus, it was conceivable that these particles—although neu-
tralized by antibody binding—stimulated macropinocytosis,
resulting in the co-internalization of intact EVs. To test
whether MVs stimulated the internalization of EVs, we
performed infection assays with a GFP-expressing version
of the mutant virus WR DA34R, a virus that produces B90%
intact EVs (Figure 4D). EV infection was reduced by the same
Figure 3 EV internalization by ﬂow cytometry. IHD-J F13–GFP EVs (MOI 175) were bound to HeLa cells on ice for 1h and cells incubated at
0o r3 7 1C for 30min. To detect internalized EVs (int.), bound virions were removed and cells were detached with trypsin; to measure total
cell-associated virions (total), cells were detached with EDTA. Cells were ﬁxed, and green ﬂuorescence quantiﬁed by ﬂow cytometry.
Representative histograms of untreated samples are shown in (A); green ﬂuorescence intensity from three independent experiments was
quantiﬁed and the average of measured geometric means of internalized (B) and total (C) EVs is displayed±s.e.m.
Figure 2 EV internalization by ﬂuorescence and electron microscopy. (A–D) IHD-J F13–GFP EVs (A–C) or IHD-J mCherry–A5 F13–GFP EVs
(D) were bound to HeLa cells on ice for 1h (MOI 15). EV particles were stained with VMC-20 (anti-B5) directly (A) or after incubation at 371C
for 30min (B–D). VMC-20 staining was performed either under non-permeabilizing (non-perm.) conditions to visualize bound virions (A, B,
D) or under permeabilizing (perm.) conditions to visualize bound and internalized virions (C). Images were recorded by confocal microscopy
and representative maximum projections of Z-stacks are shown. Arrows in the inset of B highlight F13–GFP-containing EV membranes not
accessible to VMC-20 staining. In the inset of (D), EV particles (arrows) and an EV membrane without a core (open arrowhead), all not
accessible to VMC-20 staining, as well as a virus core or MVwithout an EV membrane (closed arrowhead), are highlighted. Scale bars¼10 mm.
(E, F) IHD-J F13–GFP EVs were bound to HeLa cells on ice for 1h (MOI 300). Cells were incubated at 371C for 30min, ﬁxed, and subjected to
cryosectioning and immunolabelling with anti-GFP and protein A-gold. Images were recorded by transmission electron microscopy and
representative pictures are shown. Arrows in (F) highlight MV and EV membranes. Mi, mitochondrion; Nu, nucleus. Scale bars¼200nm.
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It was sensitive to Iressa, CalC, Rott, ML-7, IPA-3, actin
perturbants, and EIPA, indicating that EV uptake by macro-
pinocytosis was not inﬂuenced by the presence of neutra-
lized, disrupted EVs or neutralized MVs. Along the same
lines, we tested if the addition of excess amounts of neutra-
lized MVs would boost infection by WR DA34R EVs
(Supplementary Figure S3). Even when a 25-fold excess of
neutralized MVs was used, no boost in EV infection was
observed. These results indicated that VACV EVs of IHD-J and
WR strains are capable of triggering macropinocytosis, result-
ing in internalization and productive infection of host cells.
EV particles induce macropinocytosis
Macropinocytosis can be distinguished from other types of
endocytosis by a dramatic rearrangement of the actin cytos-
keleton and by enhanced cellular ﬂuid-phase uptake (Mercer
and Helenius, 2009). To investigate cellular phenotypes of
macropinocytosis, WR DA34R was used. The integrity of
the EV membrane on WR DA34R EV particles allowed us to
distinguish between EV- and MV-induced changes. If EVs use
macropinocytosis for their internalization, increased uptake
of ﬂuid-phase markers would be expected. To test this, uptake
of 10kDa dextran-Alexa ﬂuor (AF) 488 into serum-starved
HeLa cells after stimulation with EVs and MVs was quantiﬁed
by ﬂow cytometry (Figure 5A). Indeed, uptake of dextran
during a 10-min pulse was increased by 42 and 51%, respec-
tively. In addition, we observed IHD-J F13–GFP EVs
co-localizing with 10kDa dextran-AF 594 in large intracellu-
lar vesicles (Supplementary Figure S4), suggesting that EV
particles are internalized into macropinosomes.
Uptake of ﬂuid by macropinocytosis requires the formation
of dynamic membrane protrusions. These protrusions occur
as lamellipodia, circular rufﬂes, or blebs. Functionally, they
all lead to the formation of macropinosomes of irregular size
and shape (Mercer and Helenius, 2009).
To determine if EVs induce the formation of membrane
protrusions, HeLa cells were treated with EVs of WR DA34R
EGFP–A5. MVs known to induce blebbing (Mercer and
Helenius, 2008) were used as a control. Virus particles were
bound to HeLa cells and incubated at 371C for 40min. Cells
were ﬁxed and analysed by differential interference contrast
(DIC) and wide-ﬁeld ﬂuorescence microscopy (Figure 5B and
C). A low level of membrane blebbing was observed in
mock-treated cells (3%), whereas 20–70% of all cells treated
with different amounts of EVs or MVs exhibited extensive,
systemic bleb formation.
The ﬁnding that WR DA34R EVs triggered both ﬂuid-phase
uptake and extensive blebbing conﬁrmed the capacity of
EVs to induce macropinocytosis at a level similar to that
seen for MVs.
Uptake of MVs by macropinocytosis has been shown to be
triggered by PS, a phospholipid enriched in the MV membrane.
When PS in the MV membrane is masked by the PS-binding
protein annexin V (ANX5), MV infection is almost completely
blocked (Mercer and Helenius, 2008). If EVs induce macro-
pinocytosis through a similar mechanism, EV infection would
be expected to be blocked by ANX5 as well. To test this, EVs
and MVs of WR DA34R GFP were pretreated with ANX5 and
used for infection experiments (Figure 5D). While MV infec-
tivity was reduced to 38% by ANX5, EV infection was not
affected. This suggested that VACV EVs induce macropinocy-
tosis through a different trigger than MVs.
Figure 4 Cellular factors required for EV infection. (A–D) HeLa cells were left untreated or treated with DMSO (highest used concentration),
staurosporine (Stau), genistein (Geni), wortmannin (Wort), calphostin C (CalC), rottlerin (Rott), 3-indolepropionic acid (IPA-3), Iressa (Ires),
chlorpromazine (Chlo), ML-7 (all 30min), cytochalasin D (Cyto), jasplakinolide (Jasp), or ethylisopropyl amiloride (EIPA) (all 15min). MVs or
EVs of IHD-J GFP (A), WR GFP (C), or WR DA34R GFP (D) were preincubated in the presence of drugs and in the case of EVs with 7D11 (MOI
2). Cells were infected and green ﬂuorescent cells quantiﬁed 4h p.i. by ﬂow cytometry. Infection levels were normalized to untreated samples.
(B) EV (IHD-J F13–GFP) and MV (IHD-J EGFP–A5) internalization in the presence of various drugs was quantiﬁed as described in Figure 3. The
geometric mean of green ﬂuorescence intensity of 01C samples was substracted from 371C samples and internalization normalized to untreated
samples. All experiments were performed three times independently, mean values±s.e.m. are shown.
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Macropinocytosis leads to the uptake of ﬂuid and particles
into endocytic vacuoles that subsequently undergo acidiﬁca-
tion (Mercer and Helenius, 2009). To determine if low pH was
needed for EV infection, we blocked acidiﬁcation of endocytic
organelles in HeLa cells using the vATPase inhibitor baﬁlo-
mycin A1 (BafA) and the carboxylic ionophore monensin
Figure 5 EVs and cellular phenotypes of macropinocytosis. (A) VAVC-induced ﬂuid-phase uptake. WR DA34R EVs and WR wt MVs were
bound to serum-starved HeLa cells on ice for 1.5h and cells pulsed for 10min at 371C with 10kDa dextran-AF 488. Cells were washed,
harvested, ﬁxed, and geometric means of green ﬂuorescence quantiﬁed by ﬂow cytometry. Dextran uptake was normalized to uptake by
unstimulated cells and mean values±s.e.m. of three independent experiments are shown. (B, C) VAVC-induced cell blebbing. WR DA34R
EGFP–A5 MVs or concentrated EVs were bound to HeLa cells at room temperature (RT). Cells were incubated at 371C for 40min, ﬁxed, stained,
and analysed by DIC and wide-ﬁeld ﬂuorescence microscopy. The number of total and blebbing cells from three independent experiments
(B250 cells per condition and experiment) was counted and mean±s.e.m. is shown (B). Representative images are shown in (C). Scale
bars¼20mm. (D)W RDA34R infection—ANX5. Exposed PS of concentrated EVs or MVs of WR DA34R GFP (MOI 4) was masked with ANX5.
Subsequently, virions were incubated at 371C for 1h (in case of EVs in the presence of 7D11) and used for infection experiments as described in
Figure 4. Experiments were performed three times independently, mean values±s.e.m. are shown.
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signiﬁcantly affect infection by MVs, both compounds
reduced EV infection in a dose-dependent manner. IHD-J
and WR DA34R EV infection was reduced by 80% at the
highest concentrations. WR EV infection was only reduced by
up to 65%. Infection with IHD-J EVs was also blocked by
BafA in several other cell lines including A549N, BSC-40,
RK13, and Vero (data not shown).
Thus, acidiﬁcation of endocytic vesicles was required for
efﬁcient infection by intact EVs, whereas MVs were less
sensitive to the perturbants of vacuolar acidiﬁcation at the
concentrations used.
Figure 6 EV infection and acidiﬁcation of endocytic vacuoles. Experimental setup as in Figure 4; HeLa cells were pretreated with BafA (A–C)
or MonA (D–F) for 1h; controls with solvents at the highest used concentrations were included. Infection with IHD-J GFP (A, D), WR GFP
(B, E), or WR DA34R GFP (C, F) in the presence of drugs was quantiﬁed by ﬂow cytometry; mean±s.e.m. of three independent, normalized
experiments are shown.
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To determine which step(s) in the entry process required low
pH, we quantiﬁed endocytic internalization of IHD-J EVs
and MVs in the presence of BafA and MonA (Figure 7A).
Internalization into EIPA-treated cells was used as a control.
BafA did not affect EV or MV internalization. MonA reduced
internalization moderately, and EIPA strongly. This suggested
that the effect of BafA on infection occurred after EV
internalization.
To determine if the BafA-sensitive intracellular step of EV
entry involved disruption of the outer membrane of EVs in
endocytic compartments, we ﬁrst tested whether EV mem-
branes could be disrupted by low pH treatment in vitro as
previously reported (Vanderplasschen et al, 1998a). When
supernatants containing IHD-J and WR EVs were incubated
with pH 5 buffer at 371C for 5min, the fraction of 7D11-
resistant intact EVs dropped by 62 and 42%, respectively
(Figure 7B). The fraction of intact WR DA34R EVs was not
signiﬁcantly altered, suggesting that EV membranes of this
mutant cannot be disrupted by low pH in vitro. When
ﬂuorescent EV particles of strain IHD-J mCherry–A5 F13–
GFP were subjected to the same treatment and bound to
cover slips, however, no signiﬁcant loss of F13–GFP ﬂuores-
cence was detected (data not shown), suggesting that dis-
rupted EV membranes remained associated with the
underlying virus particle.
The observed increase in 7D11 sensitivity upon low pH
treatment suggested that the BafA-sensitive step of EV entry
may involve rupture of the EV membrane within acidiﬁed
endocytic compartments. If this were the case, infection in
the presence of BafA might be rescued if EV membranes were
artiﬁcially disrupted before internalization. To test this, 7D11-
treated EVs were bound to HeLa cells in the cold and cells
treated for 5min at 371C with pH 7.4 or pH 4.5 medium.
Infection was quantiﬁed 4h after treatment (Figure 7C).
After neutral or low pH treatment, infection of untreated
cells with EVs of strains IHD-J (32 and 31%), and WR (20 and
20%) was similar (absolute data not shown). In BafA-treated
cells, however, IHD-J and WR infection was increased by
72 and 43% in cells exposed to low pH when compared with
controls. That acid-induced disruption of EV membranes
partly rescued infection in cells with impaired macropinoso-
mal acidiﬁcation suggested that EV membrane disruption
was indeed the step in EV entry that was inhibited by BafA.
Infection with WR DA34R EVs in the presence of BafA was
not increased after low pH treatment. This was consistent
with the ﬁnding that low pH did not trigger disruption of the
EV membrane of this strain in vitro.
If EV membrane disruption required acidiﬁcation of
endocytic vesicles, intact EV particles would be expected to
accumulate in those compartments when acidiﬁcation is
inhibited by BafA. To test this, we infected HeLa cells with
IHD-J mCherry–A5 F13–GFP EVs for 3h in the absence or
presence of BafA. Disrupted EVs were not neutralized with
7D11 in this experiment as they would accumulate in macro-
pinosomes making them indistinguishable from accumulated
intact EVs. To prevent early gene expression, which hampers
microscopic analysis due to transient cell rounding, micro-
Figure 7 EV internalization and acid-mediated EV membrane disruption. (A) IHD-J—internalization. EV (IHD-J F13–GFP) and MV (IHD-J
EGFP–A5) internalization in the presence of BafA, MonA, and EIPA was quantiﬁed as described in Figure 4B. (B) In vitro EV membrane
disruption. IHD-J, WR, and WR DA34R EVs were incubated at pH 5.0 or pH 7.4 and 371C for 5min. EVs were titrated with or without 7D11 at
pH 7.4 as described in Figure 1A. The percentage of intact EVs was calculated by normalizing plaque numbers after 7D11 neutralization to
plaque numbers in untreated samples; mean values±s.e.m. of three independent experiments are presented. (C) EV infection—acid bypass of
BafA block. HeLa cells were left untreated or treated with BafA for 1h. EVs of IHD-J GFP, WR GFP, or WR DA34R GFP were preincubated in the
presence of drugs and 7D11 for 1h at 371C (MOI 2). Virus particles were bound to cells on ice. Cells were shifted to 371C in pH 7.4 or pH 4.5
medium for 5min and then incubated in full medium with drugs for 4h. Infected cells were quantiﬁed by ﬂow cytometry. The percentage of
infected cells was normalized to the untreated samples. All experiments were performed three times independently, mean values±s.e.m. are
shown, asterisks mark signiﬁcant differences (Po0.05).
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(MOI 25) (A, B) or 7D11-treated IHD-J EGFP–A5 EVs (MOI 8 after 7D11 incubation) (C–E) in the presence of 5mg/ml ActD and 25nM BafA
where indicated. Particles were bound to pretreated cells on ice and incubated in full DMEM with drugs at 371C for 3h. Samples were ﬁxed and
stained for actin (A, B) or L1 (Mab 7D11) and actin (C, D). (A–D) Images were recorded by confocal microscopy and representative maximum
projections of Z-stacks are shown. Arrows in the insets of (B) highlight EVs, the arrowhead marks a free EV membrane. Arrows in the insets of
(C, D) highlight released viral cores, arrowheads point at viral particles that were stained for the MV-membrane marker L1. Scale bars¼10 mm.
(E) The percentage of released cores after infection with 7D11-treated EVs, MVs, and 7D11-treated MVs in the presence of the indicated drugs
was quantiﬁed in three independent experiments. Controls with bound virus (0h) were included. Core release from 7D11-neutralized MVs was
only quantiﬁed in the presence of ActD. Mean values±s.e.m. are shown.
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of actinomycin D (ActD) (typical cells shown in Figure 8A
and B). Signiﬁcantly more EVs were observed in cells infected
in the presence of BafA (arrows B, inset) than in cells with
unperturbed acidiﬁcation. EV membranes without viral cores
were also detected (ﬁlled arrowhead, inset). These may be
the remnants of disrupted EVs, whose underlying MV-like
particles underwent fusion. Viral cores containing mCherry-
A5 that were released into the cytosol could not be reliably
detected with our confocal microscopy setup. When bound
EV particles were stained under non-permeabilizing condi-
tions, we found that the majority of EV particles that had
accumulated in the presence of BafA was internalized
(Supplementary Figure S5).
If disruption of intact EVs is inhibited in the presence of
BafA, it reasons that no MV-like particles would be exposed
and, therefore, no viral cores could be released into the host
cell cytosol by fusion. To analyse core release, we used IHD-J
EGFP–A5 EVs and exploited that VACV cores accumulate in
the presence of ActD (Pedersen et al, 2000). Using this
approach, we detected and quantiﬁed the percentage of
free viral cores within the cytoplasm 3h after infection.
To differentiate between viral cores released by fusion
and viral particles in endocytic vesicles or bound to the cell
(EVs, released MV-like particles, or MVs), virions were
stained for the presence of the MV-membrane protein L1
(Figure 8C–E; Supplementary Figure S6). In addition, EVs
were treated with 7D11 before infection, preventing any core
release from disrupted EVs or contaminating MVs. Untreated
MVs and MVs neutralized with 7D11 were used as controls.
In the absence of BafA, 36% of the total cores in cells infected
with intact EVs were released into the cytosol. In the presence
of BafA, the percentage of free cores was reduced to 4%,
indicating that BafA prevented release of EV-derived viral
cores into the cytosol. MV core release was only moderately
affected by BafA treatment, whereas MV neutralization with
7D11 almost completely abolished the release of cores.
Taken together, the results suggested that acidiﬁcation of
endocytic vacuoles was required for a step of EV entry after
endocytic uptake and before release of viral cores. Since
fusion of MVs was not inhibited by the concentration of
BafA used, the acid-dependent step of EVentry is most likely
the disruption of the EV membrane within endocytic com-
partments. This is further supported by the fact that artiﬁcial
disruption of the EV membrane could bypass the need for low
pH in endocytic vesicles and by the observation that EVs
accumulated within BafA-treated cells.
Discussion
With this series of experiments, we aimed at characterizing the
entry pathway of VACV EVs. We could show that EVs were
rapidly internalized by endocytosis, and that the mechanism
was virus-induced, macropinocytic, and essential for infection
by intact EVs. We found that loss of the outer EV membrane
occurred after endocytic internalization, and concluded that
acidiﬁcation of endocytic compartments was required for this
step of EV entry. Presumably, as shown in the schematic view
of the entry program in Figure 9, the inner membrane with the
EFC was exposed after EV membrane rupture. It could then
undergo fusion with the limiting membrane of the macropino-
some, resulting in core release into the cytosol.
Judging by the insensitivity to MAb 7D11, only a relatively
small fraction (10–40%) of EVs released from VACV-infected
RK13 cells and other cell types (data not shown) contained an
intact outer membrane. Although previous studies have
reported higher proportions of intact EVs (65–75%)
(Ichihashi, 1996; Vanderplasschen et al, 1998a; Law et al,
2006; Benhnia et al, 2009), it is evident that many of the EVs
released from cells possess outer membranes that are not
fully sealed (Husain et al, 2007). Although we could occa-
sionally detect free outer membranes in our preparations, the
ruptured EV membranes typically remained associated with
the particles. Rupture of the EV membranes did not affect the
virus infectivity, but it made them susceptible to antibodies
against MV antigens.
Using ﬂuorescence and electron microscopy, we could
show that EVs were internalized into HeLa cells before loss
of their outer membrane. In the ﬂuorescence microscopy
experiments, we used recombinant viruses in which the
core and the EV membrane were visualized by different
ﬂuorescent proteins. By EM, we could identify intravacuolar
virus particles with two membranes resolved, and with
immunolabelling of GFP fused to the outer membrane protein
F13. The internalization of EVs could also be conﬁrmed by
ﬂow cytometry.
The mechanism of endocytosis used by EVs to enter cells
was studied using a set of pharmacological inhibitors known
to block endocytic processes (Mercer and Helenius, 2009).
It was found that EV infection was dependent on EGFR, PKC,
smMLCK, PAK1, actin dynamics, and sodium–proton exchan-
gers. It was not affected by staurosporin, Geni, and Wort,
three kinase inhibitors known to inhibit various endocytic
mechanisms. Taken together, the inhibitor proﬁle strongly
suggested that infection by intact EVs involved macropino-
cytosis (Mercer and Helenius, 2009). We could furthermore
show that internalization of EVs was blocked by inhibitors
of PAK1, actin dynamics, and sodium–proton exchangers,
and observed EVs in intracellular vesicles positive for
the ﬂuid-phase marker dextran. Macropinocytic uptake was
conﬁrmed by experiments using WR DA34R, a mutant virus
Figure 9 Mechanism of VACV EV entry. VACV EVs induce ﬂuid-
phase uptake by macropinocytosis and are internalized with the
bulk ﬂuid. The pH in macropinosomes decreases in the course of
their maturation, which triggers disruption of the outer EV mem-
brane. Exposed EFCs in the membrane of MV-like particles catalyse
or regulate fusion with limiting endocytic membranes and thereby
release virus cores with the genome into the cytosol allowing for
successful replication.
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induce an MV-independent elevation in ﬂuid-phase uptake
and induced PM rufﬂing in the form of blebs.
A role for macropinocytosis was consistent with a recent
report showing that MVand EV internalization, as well as early
gene expression, in monocyte-derived DCs depends on macro-
pinocytosis (Sandgren et al, 2010). However, the authors only
visualized uptake of viral cores and did not follow the fate of
EV membranes. Furthermore, DCs unlike most other cell types
maintain ongoing, constitutive macropinocytosis without the
requirement for external triggers (Sallusto et al, 1995; Norbury
et al, 1997; Norbury, 2006). This is part of their function as
immune cells responsible for antigen capture and presentation.
In other cell types, including the HeLa cells used here, macro-
pinocytosis is a transient, ligand-triggered process (Mercer and
Helenius, 2009). Thus, our data showed a role for macropino-
cytosis in cell lines that do not undergo continuous, constitu-
tive macropinocytosis. For productive infection of HeLa cells,
EVs apparently induced the complete program of macropino-
cytosis starting with signal transduction, PM blebbing, and
increased ﬂuid uptake.
That MVs are also internalized by macropinocytosis has
been recently shown with a variety of virus strains and cell
types (Huang et al, 2008; Mercer and Helenius, 2008;
Laliberte and Moss, 2009; Mercer et al, 2010; Moser et al,
2010). This is perhaps not surprising considering that EVs and
MVs might be excluded from most other endocytic pathways
in non-phagocytic cells due to their size. However, the
mechanism of macropinocytosis induction was likely to be
different for the two particle types as they do not contain
common viral proteins on the surface and there is no
evidence for common cellular components. In contrast
to MV infection, EV infection was not inhibited by the
PS-binding protein ANX5. Evidently, EVs did not share the
apoptotic mimicry mechanism employed by MVs (Mercer
and Helenius, 2008). The requirement for macropinocytosis
is, however, shared with a number of virus families including
herpes- and ﬁloviruses for which the mechanism of triggering
is not clear (Coyne et al, 2007; Amstutz et al, 2008;
Karjalainen et al, 2008; Raghu et al, 2009; Kalin et al,2 0 1 0 ;
Nanbo et al, 2010; Saeed et al, 2010). Macropinocytosis as a
cellular mechanism is a potential drug target for new antiviral
agents.
The effect of BafA and MonA showed that EV-induced
infection of HeLa cells required organelle acidiﬁcation. While
internalization was not inhibited by BafA, the drug prevented
the release of viral cores from intact EVs. That disruption of
the outer EV membrane barrier within endocytic vesicles was
the affected step was supported by several observations.
First, we conﬁrmed previous reports that the EV membrane
is sensitive to low pH in vitro (Ichihashi, 1996;
Vanderplasschen et al, 1998a). Second, we observed that
artiﬁcial disruption of the EV membrane partially rescued
infection in the presence of BafA. Third, we found that
infection with EV suspensions in the absence of MAb 7D11
(containing 60–90% disrupted EVs) was signiﬁcantly
less sensitive to BafA or MonA (data not shown). Fourth,
EVs with both membranes accumulated intracellularly in the
presence of BafA. Fifth, release of viral cores from MVs was
not inhibited by the utilized BafA concentrations, suggesting
that fusion was not affected. MV-like particles wrapped in the
EV membrane differ from MVs in that they lack A26 (Ulaeto
et al, 1996). MVs of VACV strains lacking A26 were capable of
fusing at neutral pH in conditions in which MV infection
was sensitive to BafA (Chang et al, 2010), strengthening the
conclusion that fusion of MV-like particles is insensitive to
BafA. Although low pH seemed essential for EV disruption,
we cannot exclude the possibility that the interaction with
glycosaminoglycan (GAG) chains contributes to disruption as
previously suggested (Law et al, 2006). However, when the
murine cell line L and its GAG-deﬁcient derivative sog9
(Banﬁeld et al, 1995) were infected with IHD-J or WR EVs,
infection levels in both cell lines were similar, suggesting that
GAGs were not required for efﬁcient EV infection. Inhibition
of EV infection by BafA was similar in L and sog9 cells (data
not shown).
The mutant WR DA34R is interesting because the outer
membrane of its EVs is not as susceptible to disruption by
GAG chains (Law et al, 2006) and low pH (Figure 7B) as that
of wild-type virus. EVs of this virus lack the EV membrane
protein A34 and incorporate reduced amounts of two other
EV membrane proteins, B5 and A33 (Earley et al, 2008;
Perdiguero et al, 2008). Acidic residues in the membrane-
proximal stalk region of B5 are required for GAG-triggered EV
disruption (Roberts et al, 2009), and it is possible that both
GAG- and low pH-mediated EV rupture share a mechanism
that depends on B5 and A34. That WR DA34R EVs are
infectious despite their resistance to low pH-mediated dis-
ruption implies that loss of the outer membrane can be
triggered by other mechanisms. Nevertheless, infection re-
mained sensitive to acidiﬁcation inhibitors, suggesting a need
for WR DA34R EVs to pass through acidiﬁed endocytic
compartments for productive infection.
The immune system of poxvirus-infected organisms is
challenged by two distinct infectious entities, EVs and MVs,
that expose no common epitopes. The outer EV membrane
serves as a protective shield under which an MV-like particle
can hide during virus spread through body ﬂuids. Consistent
with such a role, the EV membrane contains complement
control proteins (Vanderplasschen et al, 1998b), and EVs
are more difﬁcult to neutralize with antibodies than MVs
(Law and Smith, 2001). The key viral proteins involved in
membrane fusion remain hidden and protected until needed.
The cue for disruption of the outer EV membrane is the low
pH, which the virus is likely to encounter for the ﬁrst time in
the macropinosome. Our results thus indicate that the
protective outer membrane of an incoming EV is shed at
the latest possible time point, that is when the virus has been
internalized and is no longer accessible to extracellular
factors.
Materials and methods
Cell lines
BSC-40 (African green monkey) and HeLa (human) cells were
cultivated in DMEM (Gibco BRL) supplemented with 10% heat-
inactivated FCS, glutamax, and penicillin–streptomycin; for BSC-40
cells non-essential amino acids and sodium pyruvate were added as
well; RK13 (rabbit) cells were cultivated in MEM (Gibco BRL)
supplemented with 10% heat-inactivated FCS, glutamax, non-
essential amino acids, penicillin–streptomycin, and sodium
pyruvate.
Viruses
Recombinant VACVs were generated based on VACV strain WR,
VACV WR DA34R (a kind gift of Bernard Moss, NIH, Bethesda, MD,
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described (Mercer and Helenius, 2008). Brieﬂy, GFP-expressing
strains were generated using vectors based on the plasmid pJS4
(Chakrabarti et al, 1997). Strains encoding EGFP–A5 or mCherry–
A5 in the endogenous locus were constructed using vectors based
on pBluescript II KS (Fermentas, St Leon-Rot, Germany) bearing the
EGFP or mCherry coding sequence ﬂanked by the respective VACV
WR genomic regions. VACV strains expressing F13–GFP were a kind
gift of Rafael Blasco (INIA, Madrid, Spain) (Geada et al, 2001). To
build strains encoding both mCherry–A5 and F13–GFP, BSC-40 cells
were co-infected with mCherry–A5 and F13–GFP viruses; dual-
coloured recombinants of the parental viruses were selected
through four rounds of plaque puriﬁcation on BSC-40 cells.
MV particles were produced in BSC-40 cells and puriﬁed from
cytoplasmic lysates as described elsewhere (Mercer and Helenius,
2008). EV particles were produced in RK13 cells and collected from
the supernatant. Conﬂuent tissue culture ﬂasks were infected with
the respective MVs in serum-free medium at an MOI of 1 for 1h.
Cells were washed with PBS and overlayed with full medium.
At 24h after infection, supernatants were collected and loose cells
were sedimented by two low speed centrifugation steps (400g,
10min, 41C). EV-containing supernatants were either used directly
or concentrated by sedimentation (40min, 38000g,4 1C) and
resuspended in full or serum-free medium.
Antibodies
Hybridoma cells to produce the mouse MAb 7D11 (anti-L1) (Wolffe
et al, 1995) were kindly provided by Bernard Moss with permission
of Alan Schmaljohn (University of Maryland, Baltimore, MA, USA).
MAbs were puriﬁed from hybridoma supernatants by BioGenes
(Berlin, Germany). MAb VMC-20 (anti-B5) from ascites ﬂuid was a
kind gift of Roselyn J Eisenberg and Gary H Cohen (University of
Pennsylvania, Philadelphia, PA, USA) (Aldaz-Carroll et al, 2005).
Rabbit polyclonal anti-GFP was purchased from Rockland (Gilberts-
ville, PA, USA). Fluorophore-coupled goat anti-mouse secondary
antibodies were obtained from Invitrogen (Carlsbad, CA, USA).
Drugs and reagents
ActD, BafA, CalC, Cyto, Chlo, EIPA, IPA-3, Geni, ML-7, MonA,
Rott, Stau, and Wort were obtained from Sigma-Aldrich; Jasp was
purchased from Enzo Life Sciences (Farmingdale, NY, USA) and
Iressa from LC laboratories (Woburn, MA, USA); AF 594-coupled
phalloidin (Invitrogen) was used for actin staining, Draq5 (Biosta-
tus, Shepshed, UK) for DNA staining.
EV plaque assay
To assay the fraction of intact infectious EVs, virus samples were
incubated with or without 5mg/ml MAb 7D11 at 371C for 1.5h.
Serial dilutions were prepared and 50ml of each was added to
conﬂuent BSC-40 cells in six-wells covered with 1ml DMEM. After
1h at 371C, cells were washed with 1ml PBS and overlayed with
2ml full DMEM (WR) or full DMEM with 1.5% carboxymethyl
cellulose (IHD-J). Cells were stained after 48–72h (0.1% crystal
violet, 2% formaldehyde in H2O).
Microscopic analysis of EV particles
The integrity of EVs on the particle level was analysed using
confocal microscopy. EV particles of strain IHD-J mCherry–A5 F13–
GFP from clariﬁed supernatants were incubated with 5mg/ml MAb
7D11 at 371C for 1h and bound to cover slips. Samples were ﬁxed
with formaldehyde and stained with AF 647 goat anti-mouse.
Z-stacks were recorded using a Zeiss LSM510 Meta confocal system.
Particles were detected using the ImageJ particle detector and
tracker plugin (Sbalzarini and Koumoutsakos, 2005) on Z projec-
tions (radius¼3, cutoff¼0, percentile 0.07 (green)/0.1 (blue)/0.05
(red)) and coordinates were compared with a custom-written
Matlab program (distance cutoff 43 pixels (540nm)).
Confocal microscopy internalization experiment
To assay the internalization of EVs, IHD-J EV particles (3 
concentrated supernatants) were bound to HeLa cells on cover
slips for 1h on ice. Cells were either stained directly or incubated in
full medium at 371C for 30min. Cells were cooled down, washed,
and incubated with VMC-20 (1:10000 in PBS/1% BSA) on ice for
2h. Cells were ﬁxed and stained with AF 647 goat anti-mouse and
AF 594 phalloidin (where indicated). Control samples were ﬁxed
and permeabilized before staining. Z-stacks were recorded using a
Zeiss LSM510 Meta confocal system.
Electron microscopy internalization experiment
To visualize internalized EVs, IHD-J F13–GFP EV particles (60 
concentrated supernatants) were bound to HeLa cells on ice for 1h.
Cells were incubated in full medium at 371C for 30min, and ﬁxed in
4% formaldehyde and 0.1% glutaraldehyde in 1  PHEM buffer
(Schliwa et al, 1981) for 90min. Cryosectioning and immunolabel-
ling was performed as described elsewhere (Tokuyasu, 1973;
Slot and Geuze, 2007). In brief, ultrathin sections (50–70nm) from
gelatin-embedded and frozen cell pellets were obtained using an
FC7/UC7-ultramicrotome (Leica, Vienna, Austria).
Immunogold labelling was carried out on thawed sections with
anti-GFP antibodies (1:200) and 10nm protein A-gold (UMC Utrecht
University, Utrecht, The Netherlands) (1:50); a mixture of
uranyl acetate and methyl cellulose was used for embedding and
negative staining. Sections were examined with a CM10 Philips
transmission electron microscope with an Olympus ‘Veleta’ 2k 2k
side-mounted TEM CCD camera.
Flow cytometry internalization assay
Subconﬂuent 12-wells of HeLa cells were used for ﬂow cytometry-
based internalization assays. Cells were pretreated with inhibitors
for 15–60min in full DMEM; EVs (IHD-J F13–GFP, 0.25ml 35 
concentrated supernatants) or MVs (IHD-J EGFP–A5, 7.5 10
7p.f.u.
in 0.25ml) in serum-free medium were bound to cells on ice for 1h.
Cells were washed and incubated with full medium (þinhibitors)
at 37 or 01C for 30min. Cells were washed with PBS and incubated
with 0.25% Trypsin/EDTA at 371C for 10min to detach cells and
remove bound virus. Alternatively, cells were detached with 1mM
EDTA/PBS at 01C for 30min. Cells were resuspended and washed in
7% FCS in PBS, ﬁxed and analysed using a Becton Dickinson (BD)
FACSCalibur ﬂow cytometer and the FlowJo software package.
Flow cytometry infection assay
Conﬂuent 12-wells of HeLa cells were infected for ﬂow cytometry-
based infection assays. Pretreatment with inhibitors was performed
for 15–60min in full MEM (as used for RK13 cells and present in
EV supernantants). MVs (2 10
6p.f.u. in 0.5ml) and EVs (0.5ml
EV supernatant or concentrate) were prepared in full MEM
(þinhibitors). Disrupted EVs and contaminating MVs in the EV
samples were neutralized with 5mg/ml 7D11 for 1h at 371C and
added to cells. After 30min at 371C, cells were washed and
overlayed with 1ml full MEM (þinhibitors). Four hours after
infection, cells were prepared for ﬂow cytometry. Cells were
analysed using a BD FACSCalibur ﬂow cytometer and the BD
CellQuest Pro software or the FlowJo software package.
Fluid-phase uptake assay
Virus-induced ﬂuid-phase uptake was quantiﬁed as described
previously (Meier et al, 2002). Subconﬂuent HeLa cells in 24-well
plates were serum starved in 0.2% BSA/DMEM for 4h. WR wt MVs
or WR DA34R EVs in 0.2% BSA/RPMI were then bound to the cells
in the cold for 90min. Cells were washed and pulsed for 10min at
371C with 0.5mg/ml 10kDa dextran-AF 488 (Invitrogen) in RPMI/
BSA. Cells were washed with BSA/RPMI, PBS (2 ), 100mM
NaOAc (pH 5.5)/50mM NaCl, and PBS. Cells were detached with
0.25% trypsin (25min on ice, 1min at RT), resuspended with 7%
FCS in PBS and ﬁxed in 4% formaldehyde over night at 41C.
Fluorescence of cells was quantiﬁed using a BD FACSCalibur ﬂow
cytometer and the FlowJo software package.
Blebbing assay
To quantify the induction of blebbing, HeLa cells were grown on
cover slips to 50% conﬂuency. MV or EV suspensions (0.5ml) of
WR DA34R EGFP–A5 in 2% BSA/PBS were added to cells at RT for
1h. Cells were washed and incubated with full medium at 371C for
40min. Samples were ﬁxed with 4% formaldehyde at RT, and DNA
and actin stained with Draq5 and AF 594 phalloidin. Microscopy
images were recorded using an Olympus Cell^R imaging station
with DIC setup. Total and blebbing cells were counted manually
(ntotal B250cells/condition and experiment).
Annexin V binding
Exposed PS on virion membranes was masked with ANX5 to
test the requirement of PS on infection. A modiﬁed version of the
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s Apoptosis Assay kit #2;
Molecular Probes) was used for labelling. In brief, sedimented
virions were washed twice with ANX5-binding buffer (10mM
Hepes, 140mM NaCl, 2.5mM CaCl2, pH 7.4), resuspended in 200ml
ANX5-binding buffer and split into two samples. Samples were left
untreated or treated with 20ml AF 647 ANX5 for 1h at RT. Virions
were washed twice with ANX5-binding buffer, resuspended in
DMEM and used for infection experiments.
EV disruption
To disrupt EV particles in vitro,2 0ml EVs (clariﬁed supernatant of
infected RK13 cells) were mixed with 180ml 10mM Na-citrate
(pH 5.0), incubated at 371C for 5min and neutralized with 100ml
1M Hepes pH 7.4. For controls, Hepes was added to virus samples
premixed with low pH buffer. Integrity of EVs was quantiﬁed by
plaque assay as described above.
To rescue infection by low pH treatment, 7D11-treated EV
particles were bound to drug-treated HeLa cells on ice for 1h in
the presence of drugs. Cells were incubated for 5min with full
DMEM containing 30mM MES (pH 4.5) or full DMEM (pH 7.4) at
371C. Cells were washed twice and treated as described in the ﬂow
cytometry infection assay. SigmaPlot (Systat software) was used to
compare sample groups by t-test.
Core release assay
To detect and quantify viral cores, HeLa cells on cover slips were
pretreated with inhibitors in full DMEM for 30min. IHD-J EGFP–A5
EVs (0.25ml 4  concentrated EV supernatant) or MVs
(1.3 10
7p.f.u. in 0.25ml) in 2% BSA/PBS were pretreated with
or without 5mg/ml 7D11 for 1h at 371C. Virions were bound to cells
on ice for 1h in the presence of drugs. Cells were washed with PBS
and incubated in full medium with drugs for 3h. Cells were ﬁxed
with formaldehyde, and stained with 7D11 (540ng/ml)/AF 594 goat
anti-mouse and AF 647 phalloidin. Z-stacks were recorded using a
Zeiss LSM510 Meta confocal system. Green ﬂuorescent cores were
detected with the spot detection function of Imaris (Bitplane) using
the quality parameter. Detected spots with a mean green intensity
o20 were omitted and spots with a mean red ﬂuorescent
intensity o50 were classiﬁed as released cores (ntotal B750 cores
in 10cells/condition and experiment).
Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
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